Cargando…
In Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein
BACKGROUND: Bacterial infection by antibiotic-resistant Staphylococcus aureus strains is a worldwide concern and the development of novel antistaphylococcal agents is acutely needed. Lysostaphin, an example of such novel agents, is a bacteriocin secreted by S. simulans to kill S. aureus through prot...
Autores principales: | Abtahi, Hamid, Farhangnia, Leila, Ghaznavi-Rad, Ehsanollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870841/ https://www.ncbi.nlm.nih.gov/pubmed/27217919 http://dx.doi.org/10.5812/jjm.28489 |
Ejemplares similares
-
Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans
por: Farhangnia, Leila, et al.
Publicado: (2014) -
In vivo efficiency of the produced recombinant lysostaphin antimicrobial peptide in treatment of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in a mouse model
por: Sadoogh Abbasian, Shabnam, et al.
Publicado: (2023) -
Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance
por: Blazanovic, Kristina, et al.
Publicado: (2015) -
Overexpression and Enzymatic Assessment of Antigenic Fragments of Hyaluronidase Recombinant Protein From Streptococcus pyogenes
por: Sadoogh Abbasian, Shabnam, et al.
Publicado: (2014) -
Expression and Antigenic Evaluation of VacA Antigenic Fragment of Helicobacter Pylori
por: Hasanzadeh, Leila, et al.
Publicado: (2013)